Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Structure-activity profile

Very recently, the Shipman group have made a further step towards a comprehensive structure/activity profile for noncovalent interactions between azinomycin B and DNA [152]. They synthesized simplified azinomycin analogues 69 and 96-98 (Scheme 11.13), retaining both the epoxide and aziridine alkylating functionalities, with systematically altered substitution on the naphthoate fragment, and analyzed their DNA crosslinking by gel electrophoresis. They found that cross-... [Pg.422]

Thus, a synthetic source of promising allelochemicals is essential if we are to comprehensively study the agent s mode of activity and establish its basic structure-activity profile. The proposed work addresses this need. We will synthesize alleopathic natural products isolated from the sunflower (the heliannuols), and structurally related compounds, in optically pure form based on biomimetic phenol-epoxide cyclizations. The bioactivity of the targets and intermediates will be evaluated through laboratory tests on plant germination and growth. Bioassays will be performed on the synthetic intermediates to allow for the development of a preliminary structure-activity profile for these novel natural herbicides. [Pg.423]

We also plan to perform bioassays on synthetic intermediates and target compounds to allow for development of a preliminary structure-activity profile for these novel herbicides. [Pg.428]

Dennies, T.B., Fournier, A., St. Pierre, S., Quirion, R Structure activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity, J. Pharmacol. Exp. Ther. 1989, 251, 718-725. [Pg.552]

From an additional study, modification or removal of the sugar moiety also has a substantial influence on the cytotoxic potency of eleutherobin and its cross-resistance in Taxol-resistant cells [14]. These structure/activity profiles should be usable for future design of more potent eleutherobin derivatives. [Pg.321]

Metathesis is inherently flexible. As a result, this transformation allows, inter alia, for a rapid chemistry-driven evaluation of structure/activity profiles and qualifies for applications in combinatorial and diversity oriented synthesis this is particularly true when combined with suitable post-metathesis transformations exploiting diverse alkene reactivity. [Pg.19]

The structures of selected cephalosporins on the U.S. market, or in the final stages of development, are shown in Tables 4—8 (see also 78, 87). For every cephalosporin which has made it to the marketplace, literally thousands of analogues were synthesized in order to establish the structure-activity profile and allow selection of a clinical candidate. In addition to these compounds, there is a tremendous number of cephalosporin compounds currently at various stages of development. A more extensive listing of the newer cephalosporins under predinical or clinical evaluation may be found in a number of reviews (79,88). [Pg.28]

C. Unverzagt, S. Andre, J. Seifert, S. Kojima, C. Fink, G. Srikrishna, H. Freeze, K. Kayser, and H.-J. Gabius, Structure-activity profiles of complex biantermary glycans with core fucosyl-ation and with/without additional a2,3/a2,6 sialylation Synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake, J. Med Chem., 45 (2002) 478 91. [Pg.175]

Adenosine influences adenylyl cyclase activity via an interaction with at least two distinct membrane-associated receptors. The Aj adenosine receptor mediates an inhibition of adenylate cyclase, whereas A receptor activation results in the stimulation of this enzyme (6). These receptor subtypes have been defined further by their structure-activity profiles of agonists (7-9). At Aj adenosine receptors the rank order potency of adenosine analogs is N°-(R-phenylisopropyladenosine (R-PIA) > N -ethylcarboxamidoadenosine (NECA) > 2-chloroadenosine (2-ClA) > S-PIA. In contrast at A2 adenosine receptors the potency series for these agonists is NECA > 2C1A > R-PIA > SPIA (2,2). Adenosine analogs acting on A] receptors have been shown to inhibit adenylyl cyclase in brain tissue. Moreover, the adenosine-induced depression of neuronal activity in the rat hippocampus has been shown to involve an interaction with Ai receptors (10). [Pg.233]

XRD) and, further, by in situ CO stripping and cyclic voltammetry. Subsequently, the activity towards methanol electro-oxidation was tested in steady-state experiments at 22 °C and 60 °C. Thus, a structure-activity profile was developed based... [Pg.77]

Table 29.2.3.5 shows the general structure-activity profile for six-membered neonicotinoids the most favorable structural features are highlighted below ... [Pg.998]


See other pages where Structure-activity profile is mentioned: [Pg.227]    [Pg.75]    [Pg.33]    [Pg.292]    [Pg.67]    [Pg.10]    [Pg.142]    [Pg.148]    [Pg.878]    [Pg.2099]    [Pg.240]    [Pg.323]    [Pg.81]    [Pg.156]    [Pg.281]    [Pg.282]    [Pg.282]    [Pg.283]    [Pg.199]    [Pg.62]    [Pg.616]    [Pg.823]    [Pg.243]    [Pg.250]    [Pg.286]    [Pg.112]    [Pg.112]    [Pg.225]    [Pg.252]    [Pg.51]    [Pg.79]    [Pg.407]   
See also in sourсe #XX -- [ Pg.42 , Pg.43 ]




SEARCH



Profile activity

Profiles structures

Profiling Structures

Profiling, structure-activity

Profiling, structure-activity

Structure-activity profile of taxol

© 2024 chempedia.info